Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
71,127.00
64,139.00
62,843.00
60,461.00
56,607.00
55,181.00
52,542.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
71,127.00
64,139.00
62,843.00
60,461.00
56,607.00
55,181.00
52,542.00
Raw Material Cost
36,982.00
32,803.00
32,178.00
31,876.00
30,255.00
29,798.00
28,525.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
222.00
51.00
40.00
50.00
56.00
59.00
64.00
Selling and Distribution Expenses
21,251.00
18,972.00
19,436.00
19,249.00
17,958.00
21,773.00
17,596.00
Other Expenses
683.80
698.00
468.80
417.70
354.20
-5.90
484.90
Total Expenditure (Excl Depreciation)
65,293.00
58,806.00
56,342.00
55,352.00
51,811.00
51,571.00
51,034.00
Operating Profit (PBDIT) excl Other Income
5834
5333
6501
5109
4796
3610
1508
Other Income
1,528.00
1,212.00
3,404.00
300.00
9,567.00
31.00
321.00
Operating Profit (PBDIT)
10,447.00
8,792.00
12,567.00
8,536.00
17,248.00
7,003.00
5,590.00
Interest
222.00
51.00
40.00
50.00
56.00
59.00
64.00
Exceptional Items
-148.00
-300.00
0.00
0.00
-8,141.00
-8.00
-862.00
Gross Profit (PBDT)
34,145.00
31,336.00
30,665.00
28,585.00
26,352.00
25,383.00
24,017.00
Depreciation
3,085.00
2,247.00
2,662.00
3,127.00
2,885.00
3,362.00
3,761.00
Profit Before Tax
6,991.00
6,192.00
9,862.00
5,357.00
6,163.00
3,575.00
901.00
Tax
1,366.00
1,091.00
2,316.00
1,118.00
1,873.00
861.00
252.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
5,425.00
5,101.00
7,545.00
4,238.00
4,290.00
2,713.00
649.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
5,425.00
5,101.00
7,545.00
4,238.00
4,290.00
2,713.00
649.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
200.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
5,625.00
5,101.00
7,545.00
4,238.00
4,290.00
2,713.00
649.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
70,360.00
65,310.00
61,930.00
54,533.00
48,892.00
44,510.00
41,573.00
Earnings per share (EPS)
191.1
179.95
266.49
150.08
151.22
95.63
22.94
Diluted Earnings per share
191.1
179.95
266.49
150.08
151.22
95.63
22.94
Operating Profit Margin (Excl OI)
8.2%
8.31%
10.34%
8.45%
8.47%
6.54%
2.87%
Gross Profit Margin
14.17%
13.16%
19.93%
14.03%
15.98%
12.57%
8.87%
PAT Margin
7.63%
7.95%
12.01%
7.01%
7.58%
4.92%
1.24%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 10.90% vs 2.06% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is 10.27% vs -32.39% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 17.66% vs -17.28% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 335.29% vs 27.50% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has fallen from Mar 2025
Compare Annual Results Of ASKA Pharmaceutical Holdings Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(JPY)
Change(%)
Net Sales
71,127.00
40,652.00
30,475.00
74.97%
Other Operating Income
0.00
0.00
0.00
Total Operating income
71,127.00
40,652.00
30,475.00
74.97%
Raw Material Cost
36,982.00
26,240.00
10,742.00
40.94%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
222.00
131.00
91.00
69.47%
Selling and Distribution Expenses
21,251.00
6,920.00
14,331.00
207.10%
Other Expenses
683.80
150.50
533.30
354.35%
Total Expenditure (Excl Depreciation)
65,293.00
34,796.00
30,497.00
87.65%
Operating Profit (PBDIT) excl Other Income
5,834.00
5,856.00
-22.00
-0.38%
Other Income
1,528.00
2,883.00
-1,355.00
-47.00%
Operating Profit (PBDIT)
10,447.00
11,640.00
-1,193.00
-10.25%
Interest
222.00
131.00
91.00
69.47%
Exceptional Items
-148.00
0.00
-148.00
Gross Profit (PBDT)
34,145.00
14,412.00
19,733.00
136.92%
Depreciation
3,085.00
2,901.00
184.00
6.34%
Profit Before Tax
6,991.00
8,608.00
-1,617.00
-18.78%
Tax
1,366.00
2,793.00
-1,427.00
-51.09%
Provisions and contingencies
0
0
0.00
Profit After Tax
5,425.00
5,763.00
-338.00
-5.87%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
5,425.00
5,763.00
-338.00
-5.87%
Share in Profit of Associates
0
0
0.00
Minority Interest
200.00
52.00
148.00
284.62%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
5,625.00
5,815.00
-190.00
-3.27%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
70,360.00
97,646.00
-27,286.00
-27.94%
Earnings per share (EPS)
191.10
180.72
10.38
5.74%
Diluted Earnings per share
191.10
180.72
10.38
5.74%
Operating Profit Margin (Excl OI)
8.20%
14.41%
0.00
-6.21%
Gross Profit Margin
14.17%
28.31%
0.00
-14.14%
PAT Margin
7.63%
14.18%
0.00
-6.55%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 7,112.70 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 10.90% vs 2.06% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 562.50 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 10.27% vs -32.39% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 891.90 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 17.66% vs -17.28% in Mar 2025
Annual - Interest
Interest 22.20 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 335.29% vs 27.50% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.20%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has fallen from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
